Neuropsychiatric Symptoms of Epilepsy

Recommendations

Info

254 A. Guekht 163. Bakker A, Krauss GL, Albert MS, Speck CL, Jones LR, Stark CE, et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron. 2012;74:467–74. doi: 10.1016/j.neuron.2012.03.023 . 164. Ben-Menachem E, Gilland E. Efficacy and tolerability of levetiracetam during 1-year followup in patients with refractory epilepsy. Seizure. 2003;12:131–5. doi: 10.1016/ s1059-1311(02)00251-0 . 165. Cereghino JJ, Biton V, Abou-Khalil B, Dreifuss F, Gauer LJ, Leppik I. Levetiracetam for partial seizures: results of a double-blind, randomized clinical trial. Neurology. 2000;55(2):236–42. doi: 10.1212/wnl.55.2.236 . 166. Brodie MJ, Perucca E, Ryvlin P, Ben-Menachem E, Meencke HJ. Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology. 2007;68:402–8. doi: 10.1212/01.wnl.0000252941.50833.4a . 167. Shorvon SD, Löwenthal A, Janz D, Bielen E, Loiseau P. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. European Levetiracetam Study Group. Epilepsia. 2000;41:1179–86. doi: 10.1111/j.1528-1157.2000.tb00323.x . 168. Patsalos PN. Antiepileptic drug interactions. London: Springer; 2013. doi: 10.1007/978-1-4471-2434-4 . 169. Perucca E, French J, Bialer M. Development of new antiepileptic drugs: challenges, incentives, and recent advances. Lancet Neurol. 2007;6:793–804. doi: 10.1016/ s1474-4422(07)70215-6 . 170. French JA, Gazzola DM. New generation antiepileptic drugs: what do they offer in terms of improved tolerability and safety? Ther Adv Drug Saf. 2011;2:141–58. doi: 10.1177/2042098611411127 . 171. Johannessen Landmark C, Patsalos PN. Drug interactions involving the new second- and third-generation antiepileptic drugs. Expert Rev Neurother. 2010;10:119–40. doi: 10.1586/ ern.09.136 . 172. Dhikav V, Anand K. Potential predictors of hippocampal atrophy in Alzheimer’s disease. Drugs Aging. 2011;28:1–11. doi: 10.2165/11586390-000000000-00000 . 173. Dhikav V, Anand K. Hippocampal atrophy may be a predictor of seizures in Alzheimer’s disease. Med Hypotheses. 2007;69:234–5. doi: 10.1016/j.mehy.2006.11.031 .
Chapter 15 Stress and Epilepsy Clare M. Galtrey and Hannah R. Cock Abstract The notion that stress, the physiological and/or behavioral response to event(s) interpreted as threatening to well-being, plays a role in triggering seizures or even causing epilepsy has been extensively studied in both experimental and clinical contexts. People with epilepsy consistently report stress as one of the most common triggers, although disentangling from confounders such as sleep deprivation, mood, and alcohol, and cause from effect has proved challenging. A great deal of effort (and money) has gone into pre-clinical and clinical research, including more recently functional imaging studies, such that we now have a good understanding of pathways and potential mechanisms. Similarly, there has been considerable work looking at ways to reduce stress, which can undoubtedly be of benefit in terms of psychological well-being, though may not improve seizure control. There has been very little consideration of cost-effectiveness or cost-utility thus far, which is of particular importance when there are inevitable limitations on resources. Thus beyond heightened awareness about the potential for stress and epilepsy to interact, little of this work has as yet translated into meaningful changes for clinical practice. Hopefully, further carefully directed preclinical and especially clinical research will lead to greater understanding of the interaction and benefit to patients. Keywords Epilepsy • Seizures • Stress • Mechanisms • Treatment • Epileptogenesis • Prenatal • Delayed Effects C. M. Galtrey , MA, PhD, MB BChir, MRCP Epilepsy Group , Atkinson Morley Regional Neuroscience Centre, St. George’s University Hospitals NHS Foundation Trust , Blackshaw Road , London SW17 0QT , UK e-mail: clare.galtrey@gmail.com H. R. Cock , BSc, MD, MBBS, FRCP (*) Epilepsy Group , Atkinson Morley Regional Neuroscience Centre, St. George’s University Hospitals NHS Foundation Trust , Blackshaw Road , London SW17 0QT , UK Institute of Biomedical and Medical Education, St. George’s University of London , Cranmer Terrace , London SW17 0RE , UK e-mail: hannahrc@sgul.ac.uk © Springer International Publishing Switzerland 2016 M. Mula (ed.), Neuropsychiatric Symptoms of Epilepsy, Neuropsychiatric Symptoms of Neurological Disease, DOI 10.1007/978-3-319-22159-5_15 255
Page 1 and 2:
Neuropsychiatric Symptoms of Neurol
Page 3 and 4:
Health care professionals are start
Page 5 and 6:
Editor Marco Mula Atkinson Morley R
Page 7 and 8:
vi Preface symptoms in patients wit
Page 9 and 10:
viii Foreword I who have an interes
Page 11 and 12:
x Foreword II sion, it is hardly su
Page 14 and 15:
Contents 1 Neurobehavioral Comorbid
Page 16 and 17:
Contributors Naoto Adachi , MD Adac
Page 18 and 19:
Contributors xvii Federica Provini
Page 20 and 21:
2 A. Mazarati and clinical trials.
Page 22 and 23:
4 A. Mazarati a b c Fig. 1.1 Morris
Page 24 and 25:
6 A. Mazarati deficits in MWM perfo
Page 26 and 27:
8 A. Mazarati Fig. 1.3 Behavioral p
Page 28 and 29:
10 A. Mazarati It should be noted t
Page 30 and 31:
12 A. Mazarati up, is followed by t
Page 32 and 33:
14 A. Mazarati opposite terminal ch
Page 34 and 35:
16 A. Mazarati serotonin deficiency
Page 36 and 37:
18 A. Mazarati At the same time, wh
Page 38 and 39:
20 A. Mazarati 14. Cavalheiro EA, N
Page 40 and 41:
22 A. Mazarati 57. Vezzani A, Frenc
Page 42 and 43:
24 A. Mazarati 100. Meyza KZ, Defen
Page 44 and 45:
26 A.M. Kanner and R. Ribot Despite
Page 46 and 47:
28 A.M. Kanner and R. Ribot Common
Page 48 and 49:
30 A.M. Kanner and R. Ribot symptom
Page 50 and 51:
32 A.M. Kanner and R. Ribot Impact
Page 52 and 53:
34 A.M. Kanner and R. Ribot anxiety
Page 54 and 55:
36 A.M. Kanner and R. Ribot 2. Depe
Page 56 and 57:
38 A.M. Kanner and R. Ribot 9. Beck
Page 58 and 59:
40 A.M. Kanner and R. Ribot 56. Faz
Page 60 and 61:
Chapter 3 Mania and Elation Marco M
Page 62 and 63:
3 Mania and Elation 45 A manic epis
Page 64 and 65:
3 Mania and Elation 47 some authors
Page 66 and 67:
3 Mania and Elation 49 antimanic ag
Page 68 and 69:
3 Mania and Elation 51 34. Blumer D
Page 70 and 71:
54 C. Brandt Introduction Anxiety d
Page 72 and 73:
56 C. Brandt diagnosis) and referri
Page 74 and 75:
58 C. Brandt history of several psy
Page 76 and 77:
60 C. Brandt to the speculation tha
Page 78 and 79:
62 C. Brandt Case 4.2 This is a rep
Page 80 and 81:
64 C. Brandt tant temporal lobe epi
Page 82 and 83:
66 C. Brandt 53. Swinkels WA, van E
Page 84 and 85:
Chapter 5 Delusions and Hallucinati
Page 86 and 87:
5 Delusions and Hallucinations 71 P
Page 88 and 89:
5 Delusions and Hallucinations 73 a
Page 90 and 91:
5 Delusions and Hallucinations 75 i
Page 92 and 93:
5 Delusions and Hallucinations 77 a
Page 94 and 95:
5 Delusions and Hallucinations 79 T
Page 96 and 97:
5 Delusions and Hallucinations 81 E
Page 98 and 99:
5 Delusions and Hallucinations 83 f
Page 100 and 101:
5 Delusions and Hallucinations 85 W
Page 102 and 103:
5 Delusions and Hallucinations 87 4
Page 104 and 105:
5 Delusions and Hallucinations 89 9
Page 106 and 107:
92 B. Hermann 60 50 40 30 20 10 0 A
Page 108 and 109:
94 B. Hermann Here we observe a uni
Page 110 and 111:
96 B. Hermann other aspects of memo
Page 112 and 113:
Chapter 7 Aggressive Behavior Hesha
Page 114 and 115:
7 Aggressive Behavior 101 A multice
Page 116 and 117:
7 Aggressive Behavior 103 by inter-
Page 118 and 119:
7 Aggressive Behavior 105 amygdala
Page 120 and 121:
7 Aggressive Behavior 107 It has be
Page 122 and 123:
7 Aggressive Behavior 109 spontaneo
Page 124 and 125:
7 Aggressive Behavior 111 [ 91 ] an
Page 126 and 127:
7 Aggressive Behavior 113 26. Kanne
Page 128 and 129:
7 Aggressive Behavior 115 72. Mula
Page 130 and 131:
Chapter 8 Epilepsy and Sleep: Close
Page 132 and 133:
8 Epilepsy and Sleep: Close Connect
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144 and 145:
Page 146 and 147:
Page 148 and 149:
Page 150 and 151:
Page 152 and 153:
Page 154 and 155:
142 M. Schmutz and motor signs they
Page 156 and 157:
144 M. Schmutz mechanism to be foun
Page 158 and 159:
146 M. Schmutz etiological theory h
Page 160 and 161:
148 M. Schmutz Table 9.2 Clinical c
Page 162 and 163:
150 M. Schmutz When asked to give a
Page 164 and 165:
152 M. Schmutz well [ 64 , 65 ]. Co
Page 166 and 167:
154 M. Schmutz Therapy In 1730, the
Page 168 and 169:
156 M. Schmutz As with other conver
Page 170 and 171:
158 M. Schmutz Acknowledgment I am
Page 172 and 173:
160 M. Schmutz 48. Bewley J, Murphy
Page 174 and 175:
Chapter 10 Consciousness Andrea E.
Page 176 and 177:
10 Consciousness 165 Level and Cont
Page 178 and 179:
10 Consciousness 167 of consciousne
Page 180 and 181:
10 Consciousness 169 During absence
Page 182 and 183:
10 Consciousness 171 EEG was unrema
Page 184 and 185:
10 Consciousness 173 These novel in
Page 186 and 187:
10 Consciousness 175 38. Picard F,
Page 188 and 189:
Chapter 11 Emotion Recognition Stef
Page 190 and 191:
11 Emotion Recognition 179 experien
Page 192 and 193:
11 Emotion Recognition 181 have com
Page 194 and 195:
11 Emotion Recognition 183 emotion
Page 196 and 197:
11 Emotion Recognition 185 signalin
Page 198 and 199:
11 Emotion Recognition 187 Effect o
Page 200 and 201:
11 Emotion Recognition 189 77 ]. Th
Page 202 and 203:
11 Emotion Recognition 191 26. Mele
Page 204 and 205:
11 Emotion Recognition 193 67. Davi
Page 206 and 207:
196 A.A. Sardesai and H. Ring help
Page 208 and 209:
198 A.A. Sardesai and H. Ring Why D
Page 210 and 211:
200 A.A. Sardesai and H. Ring and a
Page 212 and 213:
202 A.A. Sardesai and H. Ring retar
Page 214 and 215: 204 A.A. Sardesai and H. Ring Preva
Page 216 and 217: 206 A.A. Sardesai and H. Ring preva
Page 218 and 219: 208 A.A. Sardesai and H. Ring Parti
Page 220 and 221: 210 A.A. Sardesai and H. Ring As wi
Page 222 and 223: 212 A.A. Sardesai and H. Ring 11. R
Page 224 and 225: 214 D.W. Dunn and W.G. Kronenberger
Page 246 and 247: 236 A. Guekht Introduction Associat
Page 248 and 249: 238 A. Guekht some studies no assoc
Page 250 and 251: 240 A. Guekht et al. reported that
Page 252 and 253: 242 A. Guekht Hyperhomocysteinemia
Page 254 and 255: 244 A. Guekht Some authors offer ne
Page 256 and 257: 246 A. Guekht 11. Helmstaedter C, F
Page 258 and 259: 248 A. Guekht 52. Bernardi S, Scald
Page 260 and 261: 250 A. Guekht 90. Bandopadhyay R, L
Page 262 and 263: 252 A. Guekht 126. Park IS, Yoo SW,
Page 266 and 267: 256 C.M. Galtrey and H.R. Cock Intr
Page 268 and 269: 258 C.M. Galtrey and H.R. Cock reco
Page 270 and 271: 260 C.M. Galtrey and H.R. Cock Tabl
Page 274 and 275: 264 C.M. Galtrey and H.R. Cock a ST
Page 276 and 277: 266 C.M. Galtrey and H.R. Cock of t
Page 278 and 279: 268 C.M. Galtrey and H.R. Cock admi
Page 280 and 281: 270 C.M. Galtrey and H.R. Cock Stre
Page 282 and 283: 272 C.M. Galtrey and H.R. Cock of m
Page 284 and 285: 274 C.M. Galtrey and H.R. Cock Psyc
Page 290 and 291: 280 C.M. Galtrey and H.R. Cock Conc
Page 292 and 293: 282 C.M. Galtrey and H.R. Cock 24.
Page 298 and 299: Chapter 16 Epilepsy in Psychiatric
Page 300 and 301: 16 Epilepsy in Psychiatric Disorder
Page 312 and 313: Chapter 17 The Role of Epilepsy Sur
Page 314 and 315:
17 The Role of Epilepsy Surgery 305
Page 316 and 317:
Page 318 and 319:
Page 320 and 321:
Page 322 and 323:
Page 324 and 325:
Page 326 and 327:
Page 328 and 329:
Page 330 and 331:
Page 332 and 333:
Page 334 and 335:
Page 336 and 337:
Page 338 and 339:
Page 340 and 341:
Page 342 and 343:
Chapter 18 The Role of Antiepilepti
Page 344 and 345:
18 The Role of Antiepileptic Drugs
Page 346 and 347:
Page 348 and 349:
Page 350 and 351:
Page 352 and 353:
Page 354 and 355:
Page 356 and 357:
Page 358 and 359:
Page 360 and 361:
Page 362 and 363:
Page 364 and 365:
Page 366 and 367:
Page 368 and 369:
Page 370 and 371:
Chapter 19 The Role of Stimulation
Page 372 and 373:
19 The Role of Stimulation Techniqu
Page 374 and 375:
Page 376 and 377:
Page 378 and 379:
Page 380 and 381:
Page 382 and 383:
Page 384 and 385:
Page 386 and 387:
show all

Neuropsychiatric Symptoms of Epilepsy

Create successful ePaper yourself

Delete template?

Save as template?